Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences RNA-Seq, Digital PCR, and Liquid Biopsies: Capturing Value from Circulating Biomarkers

Mark Connelly's Biography



Mark Connelly, Chief Industrial Operations and R&D Officer, U.S., Menarini Silicon Biosystems, Inc.

Mark C. Connelly, Ph.D., is Chief Industrial Operations and Research & Development Officer, US for Menarini Silicon Biosystems. He has been leading research and development in the field of rare cell detection and analysis for over 15 years. Dr. Connelly previously served as Vice President of Reagent Development for Immunicon Corporation; Veridex, LLC; and Scientific Director for Janssen Diagnostics. Over the last 30 years, Dr. Connelly has lead the development and commercialization of numerous IVD and RUO products and services in the fields of Clinical Chemistry, Retrovirology, Flow Cytometry, Blood Banking, Autoimmunity, Cancer Diagnostics, and Pharmaceutical Drug Development. Dr. Connelly received his B.S. in Biology from Syracuse University, and his Ph.D. in Immunochemistry from the University of Rochester.

Mark Connelly Image

Clinical Utility and Deployment of CTCs

Monday, 21 March 2016 at 16:30

Add to Calendar ▼2016-03-21 16:30:002016-03-21 17:30:00Europe/LondonClinical Utility and Deployment of CTCsSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonRNA-Seq, Digital PCR, and Liquid Biopsies: Capturing Value from Circulating BiomarkersSELECTBIOenquiries@selectbiosciences.com